for more, i'm joined by shannon pettypiece and also steve brozak , president of an investment bank thatpecializes in the pharmaceutical industry. shannon, i know you wrote the story today and have been following what is going on. swap of ao do with a variety of properties. inartis, which is based switzerland, glaxosmithkline, which is based in u.k., and eli lilly to my based in indianapolis. >> it is interesting to see all of these big pharmaceutical ceos and executives that usually can keep with each other come together. other comewith each together. basically, what you need to know is novartis is getting bigger into cancer. bigger intoting vaccines. and eli lilly is getting bigger into animal health. the bigger themes across all of these countries -- companies is that they are trying to focus on what they do best. it is not, let's do everything for everyone and you have to be big. focusing on not one thing, but a few things. >> novartis, one of the things they want to focus on is cancer drugs. >> right. >> and one of the things that glaxo smith klein wants to focus on is the vaccine b

for more, i'm joined by shannon pettypiece and also steve brozak, president of an investment bank thatpecializes in the pharmaceutical industry. shannon, i know you wrote the story today and have been following what is going on. this has to do with a swap of a variety of properties. novartis, which is based in switzerland, glaxosmithkline, which is based in u.k., and eli lilly to my based in indianapolis. >> it is interesting to see all of these big pharmaceutical ceos and executives that usually can compete with each other come together. basically, what you need to know is novartis is getting bigger into cancer. glaxo is getting bigger into vaccines. and eli lilly is getting bigger into animal health. the big themes across all of these companies is that they are trying to focus on what they do best. it is not, let's do everything for everyone and you have to be big. now, it is about focusing on not one thing, but a few things. >> novartis, one of the things they want to focus on is cancer drugs. >> right. >> and one of the things that glaxo smith klein wants to focus on is the vaccine

. >> joining me now to talk about the 8 million mark and political ramifications, shannon pettypiece dr. larry is sabitow. shannon, we know that 8 million signed up. what else do we need to know before we can properly assess the economic viability of the affordable care act? >> we need to know the health of the 8 million people. that is crucial to know if the plans will stay affordable. under the law, the only information insurers are able to collect are how old think are and where they live and whether or not they smoked. they don't know anything about their overall health. that is what we will find out about in the coming months as they go to the doctor's offices and submit claims. we will find out how healthy these 8 million people are. >> larry, republicans want to know how many of them have paid. >> sure. that is one of the things they want to know. you know, fundamentally, michael, this new number doesn't change the politics of obamacare. we debated it for years. every piece of new information goes in one ear and out the other. democrats are overwhelmingly in favor. republicans

shannon pettypiece looked into this now and joins me in the studio.us about the case choice ambulance. how'd do the federal officials allege their gaming the system? >> this is a particularly egregious case but not unusual. the dialysisside center. they were waiting for patients who could walk and get to the treatment on their own. can were telling them we get medicare to pay for your trip to dialysis for free in one of our ambulances. are usedow ambulances for emergencies and people who get toill they cannot their doctors appointment any other way. this company was taking patients who could walk or sit and stand just fine, putting them in ambulances transporting them back and forth, and charging medicare, some cases more than a thousand dollars a week to give patients rides in their ambulances. >> how widespread is this? >> this is a particularly egregious case. there was one man who used to smoke cigarettes in the front seat of the ambulance on his way back and sometimes they would have to patients in the ambulance in the back writing to their treat